A carregar...
Recombinant human erythropoietin improves neurological outcomes in very preterm infants
OBJECTIVE: To evaluate the efficacy and safety of repeated low‐dose human recombinant erythropoietin (rhEPO) in the improvement of neurological outcomes in very preterm infants. METHODS: A total of 800 infants of ≤32‐week gestational age who had been in an intensive care unit within 72 hours after b...
Na minha lista:
| Publicado no: | Ann Neurol |
|---|---|
| Main Authors: | , , , , , , , , , |
| Formato: | Artigo |
| Idioma: | Inglês |
| Publicado em: |
John Wiley and Sons Inc.
2016
|
| Assuntos: | |
| Acesso em linha: | https://ncbi.nlm.nih.gov/pmc/articles/PMC5084793/ https://ncbi.nlm.nih.gov/pubmed/27130143 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1002/ana.24677 |
| Tags: |
Adicionar Tag
Sem tags, seja o primeiro a adicionar uma tag!
|